https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20231 Wed 11 Apr 2018 15:51:09 AEST ]]> Patient-Reported Urinary and Bowel Quality of Life Outcomes Following External Beam Radiotherapy with or without High-Dose-Rate Brachytherapy Boost: Post-Hoc Analyses of TROG 03.04 (RADAR) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53707 Wed 10 Jan 2024 11:03:19 AEDT ]]> Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: results from a large pooled population https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25777 1. DVHs of anorectum were reduced to equivalent uniform dose (EUD). The best-value of the volume parameter n was determined through numerical optimization. Association between EUD/clinical factors and the endpoints was investigated by logistic analyses. Likelihood, Brier-score and calibration were used to evaluate models. External calibration was also carried out. Results: 4% of patients (45/1122) reported mean stool frequency grade >1; grade ≥2 rectal pain was present in the TROG 03.04 RADAR population only (21/677, 3.1%): for this endpoint, the analysis was limited to this population. Analysis of DVHs highlighted the importance of mid-range doses (30-50Gy) for both endpoints. EUDs calculated with n=1 (OR=1.04) and n=0.35 (OR=1.06) were the most suitable dosimetric descriptors for stool frequency and rectal pain respectively. The final models included EUD and cardiovascular diseases (OR=1.78) for stool frequency and EUD and presence of acute gastrointestinal toxicity (OR=4.2) for rectal pain. Conclusion: Best predictors of stool frequency and rectal pain are consistent with findings previously reported for late faecal incontinence, indicating an important role in optimization of mid-range dose region to minimize these symptoms highly impacting the quality-of-life of long surviving patients.]]> Thu 03 Feb 2022 12:18:50 AEDT ]]> Dosimetric intercomparison for multicenter clinical trials using a patient-based anatomic pelvic phantom https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14366 Sat 24 Mar 2018 08:23:11 AEDT ]]> Two non-parametric methods for derivation of constraints from radiotherapy dose-histogram data https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20796 Sat 24 Mar 2018 08:05:59 AEDT ]]> Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32074 Mon 23 Sep 2019 11:51:28 AEST ]]>